Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Genedrive gets UK CYP2C19-ID test boost

31st Jul 2024 11:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

----------

AIM - WINNERS

----------

Genedrive PLC, up 20% at 4.55 pence, 12-month range 1.21p-12.30p. The UK National Institute for Health & Care Excellence recommends has chosen Genedrive's CYP2C19-ID test as a "preferred platform for point-of-care genotype testing" to guide for clopidogrel use after strokes. Clopidogrel is a medication used to reduce heart disease risk. The point of care pharmacogenetic testing company says it will now "actively pursue commercialisation in the UK and Middle Eastern countries".

----------

Condor Gold PLC, up 15% at 23.50 pence, 12-month range 13.50p-37.00p. The firm, developing La India gold project in Nicaragua, reports that there "remains substantial interest from gold producers to acquire the company's assets". "There are currently eleven companies under NDAs, five non-binding offers received and three site visits completed. Whilst discussions have ceased with one gold producer previously referred to, the company is now focused on active discussions with three other gold producers, one of which we consider the preferred bidder," Chair Jim Mellon says.

----------

AIM - LOSERS

----------

UK Oil & Gas Ltd, down 25% at 0.057p, 12-month range 0.013p-0.56p. The stock surrenders some gains after a rip-roaring rise in recent days. The oil and gas exploration and production firm, with assets in UK and Turkey, last week Thursday said it is now debt free. Shares are up almost three-fold since then.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to [email protected]

Copyright 2024 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value8,306.54
Change-11.70